NCT02859168

Myofascial Induction in Breast Cancer Survivors

Randomized, Single-blind, Placebo-controlled Cross-over Design of Myofascial Induction and Placebo Electrotherapy in Breast Cancer Survivors

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Universidad de Granada · Academic / Other
• Sex: Female
• Age: 25 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to show the immediate effects of myofascial induction on perceived pain and anxiety, cervical/shoulder range of motion and mood state in breast cancer survivors suffering shoulder/arm morbidity.

Detailed description

Background: To investigate the immediate effects of myofascial induction on perceived pain and anxiety, cervical/shoulder range of motion and mood state in breast cancer survivors suffering shoulder/arm morbidity. Methods: Randomized, single-blind, placebo-controlled cross-over study. Twenty-one enrolled participants who had a diagnosis of breast cancer stage I-IIIA and had completed adjuvant therapy except hormonal treatment. The study consisted of two intervention sessions of 30 minutes separated by a wash-up period of 4 weeks. The interventions consisted of a Myofascial Induction (experimental group) or placebo pulsed shortwave therapy (control group). The main outcome measures were: Visual Analogue Scale for pain and anxiety, shoulder-cervical goniometry for range of motion, Profile of Mood States for psychological distress and Attitudes Toward Massage Scale.

Conditions

• Pain
• Breast Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Myofascial Induction	Patients received a Myofascial Induction focused on the upper limb area for 30 minutes using the Pilat approach.
DEVICE	Unplugged pulsed shortwave therapy	Patients received a placebo session consisted of 30 minutes of unplugged pulsed shortwave therapy.

Timeline

• Start date: 2014-06-01
• Primary completion: 2017-08-01
• Completion: 2017-10-01
• First posted: 2016-08-08
• Last updated: 2021-10-18

Locations

1 site across 1 country: Spain